tiprankstipranks
Advertisement
Advertisement

Regis Healthcare Director Carmel Monaghan Acquires Initial Shareholding

Story Highlights
Regis Healthcare Director Carmel Monaghan Acquires Initial Shareholding

Claim 55% Off TipRanks

Regis Healthcare Ltd. ( (AU:REG) ) has provided an update.

Regis Healthcare has disclosed a change in director Carmel Anne Monaghan’s interests, with the director acquiring 2,200 ordinary shares in the company. The on-market purchase, completed on 25 February 2026 for a total consideration of $15,164.46, marks Monaghan’s first recorded shareholding in Regis, aligning her financial interests more closely with those of shareholders and signalling confidence in the company’s prospects.

The company reported that there were no associated disposals or changes to interests in contracts, and the trade did not occur during a closed period that would have required prior written clearance. This straightforward increase in director share ownership is likely to be viewed positively by investors as it strengthens governance alignment and indicates board-level commitment to Regis Healthcare’s future performance.

The most recent analyst rating on (AU:REG) stock is a Buy with a A$8.50 price target. To see the full list of analyst forecasts on Regis Healthcare Ltd. stock, see the AU:REG Stock Forecast page.

More about Regis Healthcare Ltd.

Regis Healthcare Ltd is an Australian aged care provider operating residential aged care facilities and related healthcare services. The company focuses on delivering long-term care and support for elderly residents across its national network of facilities, operating within the regulated aged care and health services industry.

Average Trading Volume: 686,769

Technical Sentiment Signal: Buy

Current Market Cap: A$2.11B

For a thorough assessment of REG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1